WASHINGTON (AP) — The Trump administration's coronavirus vaccine effort is coming under new scrutiny after failing to lock in a chance to buy millions of additional doses of Pfizer’s vaccine, which has shown to be highly effective against COVID-19.

That decision could delay the delivery of a second batch of doses until manufacturer Pfizer fulfills other international contracts.

The revelation comes as President Donald Trump plans to host a White House summit aimed at celebrating the expected approval of the first vaccine later this week. Officials from President-elect Joe Biden’s transition team were not invited.

All contents © copyright 2020 Associated Press. All rights reserved
KGAB logo
Enter your number to get our free mobile app

Here Is How To Blur Your Home On Google Street View

More From KGAB